AnaptysBio Inc (NASDAQ:ANAB)
| 18.76 Delayed Data As of Jun 06 |  -0.05 / -0.27%Today’s Change | 18.03 Today|||52-Week Range 32.44 | -39.46% Year-to-Date |
Latest ANAB News | Press Releases
No recent news for AnaptysBio Inc.
Today’s Trading
| Previous close | 18.81 |
| Today’s open | 18.79 |
| Day’s range | 18.69 - 19.03 |
| Volume | 4,522 |
| Average volume (3 months) | 223,450 |
| Market cap | $496.6M |
Data as of 3:59pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | -116.92% |
| Earnings growth (this year) | -46.12% |
| Earnings growth (next 5 years) | +1.20% |
| Revenue growth (last year) | -83.72% |
| P/E ratio | NM |
| Price/Sales | 84.85 |
| Price/Book | 2.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUTLAutolus Therapeutics... | 0.00 | 0.00% |
| FATEFate Therapeutics In... | +0.35 | +6.78% |
| VYGRVoyager Therapeutics... | +0.85 | +7.25% |
| ALPNAlpine Immune Scienc... | +0.10 | +0.93% |
Data as of 4:00pm ET, 06/06/2023
Financials
| Next reporting date | August 7, 2023 |
| EPS forecast (this quarter) | -$1.63 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$128.7M |
| Net profit margin | -1,251.33% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
